Cargando…
Tumour Cell Lines HT-29 and FaDu Produce Proinflammatory Cytokines and Activate Neutrophils In Vitro: Possible Applications for Neutrophil-Based Antitumour Treatment
There is evidence that polymorphonuclear neutrophils (PMNs) can exert severe antineoplastic effects. Cross-talk between tumour cells and endothelial cells (ECs) is necessary for the accumulation of PMN around a tumour. This work reports the ability of two PMN-sensitive, human, permanent cell lines—c...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2821782/ https://www.ncbi.nlm.nih.gov/pubmed/20169105 http://dx.doi.org/10.1155/2009/817498 |
_version_ | 1782177469761060864 |
---|---|
author | Brú, Antonio Souto, Juan-Carlos Alcolea, Sonia Antón, Rosa Remacha, Angel Camacho, Mercedes Soler, Marta Brú, Isabel Porres, Amelia Vila, Luis |
author_facet | Brú, Antonio Souto, Juan-Carlos Alcolea, Sonia Antón, Rosa Remacha, Angel Camacho, Mercedes Soler, Marta Brú, Isabel Porres, Amelia Vila, Luis |
author_sort | Brú, Antonio |
collection | PubMed |
description | There is evidence that polymorphonuclear neutrophils (PMNs) can exert severe antineoplastic effects. Cross-talk between tumour cells and endothelial cells (ECs) is necessary for the accumulation of PMN around a tumour. This work reports the ability of two PMN-sensitive, human, permanent cell lines—colorectal adenocarcinoma (HT-29) and pharyngeal squamous-cell carcinoma (FaDu) cells—to act as inflammatory foci. PMNs were cytotoxic to both lines, the adhesion of the PMNs to the tumour cells being important in this effect. The tumour cells released appreciable amounts of IL-8 and GROα, and induced the transmigration of PMN through human microvascular-EC monolayers. Conditioning media associated with both lines induced the adhesion of PMN and the surface expression of ICAM-1 in microvascular-EC. In addition, FaDu-conditioning-medium strongly induced the production of proinflammatory cytokines by microvascular-EC. These results support the idea that tumour cells might normally induce a potent acute inflammatory response, leading to their own destruction. |
format | Text |
id | pubmed-2821782 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-28217822010-02-18 Tumour Cell Lines HT-29 and FaDu Produce Proinflammatory Cytokines and Activate Neutrophils In Vitro: Possible Applications for Neutrophil-Based Antitumour Treatment Brú, Antonio Souto, Juan-Carlos Alcolea, Sonia Antón, Rosa Remacha, Angel Camacho, Mercedes Soler, Marta Brú, Isabel Porres, Amelia Vila, Luis Mediators Inflamm Research Article There is evidence that polymorphonuclear neutrophils (PMNs) can exert severe antineoplastic effects. Cross-talk between tumour cells and endothelial cells (ECs) is necessary for the accumulation of PMN around a tumour. This work reports the ability of two PMN-sensitive, human, permanent cell lines—colorectal adenocarcinoma (HT-29) and pharyngeal squamous-cell carcinoma (FaDu) cells—to act as inflammatory foci. PMNs were cytotoxic to both lines, the adhesion of the PMNs to the tumour cells being important in this effect. The tumour cells released appreciable amounts of IL-8 and GROα, and induced the transmigration of PMN through human microvascular-EC monolayers. Conditioning media associated with both lines induced the adhesion of PMN and the surface expression of ICAM-1 in microvascular-EC. In addition, FaDu-conditioning-medium strongly induced the production of proinflammatory cytokines by microvascular-EC. These results support the idea that tumour cells might normally induce a potent acute inflammatory response, leading to their own destruction. Hindawi Publishing Corporation 2009 2010-02-11 /pmc/articles/PMC2821782/ /pubmed/20169105 http://dx.doi.org/10.1155/2009/817498 Text en Copyright © 2009 Antonio Brú et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Brú, Antonio Souto, Juan-Carlos Alcolea, Sonia Antón, Rosa Remacha, Angel Camacho, Mercedes Soler, Marta Brú, Isabel Porres, Amelia Vila, Luis Tumour Cell Lines HT-29 and FaDu Produce Proinflammatory Cytokines and Activate Neutrophils In Vitro: Possible Applications for Neutrophil-Based Antitumour Treatment |
title | Tumour Cell Lines HT-29 and FaDu Produce Proinflammatory Cytokines and Activate Neutrophils In Vitro: Possible Applications for Neutrophil-Based Antitumour Treatment |
title_full | Tumour Cell Lines HT-29 and FaDu Produce Proinflammatory Cytokines and Activate Neutrophils In Vitro: Possible Applications for Neutrophil-Based Antitumour Treatment |
title_fullStr | Tumour Cell Lines HT-29 and FaDu Produce Proinflammatory Cytokines and Activate Neutrophils In Vitro: Possible Applications for Neutrophil-Based Antitumour Treatment |
title_full_unstemmed | Tumour Cell Lines HT-29 and FaDu Produce Proinflammatory Cytokines and Activate Neutrophils In Vitro: Possible Applications for Neutrophil-Based Antitumour Treatment |
title_short | Tumour Cell Lines HT-29 and FaDu Produce Proinflammatory Cytokines and Activate Neutrophils In Vitro: Possible Applications for Neutrophil-Based Antitumour Treatment |
title_sort | tumour cell lines ht-29 and fadu produce proinflammatory cytokines and activate neutrophils in vitro: possible applications for neutrophil-based antitumour treatment |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2821782/ https://www.ncbi.nlm.nih.gov/pubmed/20169105 http://dx.doi.org/10.1155/2009/817498 |
work_keys_str_mv | AT bruantonio tumourcelllinesht29andfaduproduceproinflammatorycytokinesandactivateneutrophilsinvitropossibleapplicationsforneutrophilbasedantitumourtreatment AT soutojuancarlos tumourcelllinesht29andfaduproduceproinflammatorycytokinesandactivateneutrophilsinvitropossibleapplicationsforneutrophilbasedantitumourtreatment AT alcoleasonia tumourcelllinesht29andfaduproduceproinflammatorycytokinesandactivateneutrophilsinvitropossibleapplicationsforneutrophilbasedantitumourtreatment AT antonrosa tumourcelllinesht29andfaduproduceproinflammatorycytokinesandactivateneutrophilsinvitropossibleapplicationsforneutrophilbasedantitumourtreatment AT remachaangel tumourcelllinesht29andfaduproduceproinflammatorycytokinesandactivateneutrophilsinvitropossibleapplicationsforneutrophilbasedantitumourtreatment AT camachomercedes tumourcelllinesht29andfaduproduceproinflammatorycytokinesandactivateneutrophilsinvitropossibleapplicationsforneutrophilbasedantitumourtreatment AT solermarta tumourcelllinesht29andfaduproduceproinflammatorycytokinesandactivateneutrophilsinvitropossibleapplicationsforneutrophilbasedantitumourtreatment AT bruisabel tumourcelllinesht29andfaduproduceproinflammatorycytokinesandactivateneutrophilsinvitropossibleapplicationsforneutrophilbasedantitumourtreatment AT porresamelia tumourcelllinesht29andfaduproduceproinflammatorycytokinesandactivateneutrophilsinvitropossibleapplicationsforneutrophilbasedantitumourtreatment AT vilaluis tumourcelllinesht29andfaduproduceproinflammatorycytokinesandactivateneutrophilsinvitropossibleapplicationsforneutrophilbasedantitumourtreatment |